-
Loading metrics
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
- Nina Kimer,
- Natasja Stæhr Gudmann,
- Julie Steen Pedersen,
- Søren Møller,
- Mette Juul Nielsen,
- Diana Julie Leeming,
- Morten Asser Karsdal,
- Holger Jon Møller,
- Flemming Bendtsen,
- Henning Grønbæk
x
- Published: September 5, 2018
- https://doi.org/10.1371/journal.pone.0203200